Claritev Stock News

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Second Quarter 2025 Earnings Conference Call.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV) today announced that the PHCS Network, the largest primary PPO in the nation, received its 12th consecutive Accreditation in Credentialing from the National Committee for Quality Assurance (NCQA), a private nonprofit organization dedicated to improving health care quality. The PHCS Network is the only ...

SAN FRANCISCO--(BUSINESS WIRE)--Fractional AI, a leading provider of bespoke generative AI solutions, today announced a new collaboration with Claritev, formerly known as MultiPlan. This collaboration aims to support Claritev's generative AI strategy by establishing a robust technical and strategic foundation for transformative AI initiatives across Claritev. “Claritev is approaching AI with bo...

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #CTEV--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent, and fair for all, today announced it has joined the Coalition for Health AI (“CHAI”). CHAI is an industry-led coalition committed to developing industry best practices and fra...

MCLEAN, Va. & ABU DHABI, United Arab Emirates--(BUSINESS WIRE)---- $CTEV #CTEV--Claritev Corporation (“Claritev”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa (“MENA”) region and the market outside the United States with the appointm...

SAN DIEGO--(BUSINESS WIRE)-- #5hmC--ClearNote Health's Avantect Pancreatic Cancer Test will now be available to members accessing Claritev's national PHCS and MultiPlan Networks.

Claritev Corporation (MPLN) Q4 2024 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025.